A Study to Evaluate the Safety and Pharmacokinetics of Ataluren in Participants From ≥6 Months to < 2 Years of Age With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)
Condition: Duchenne Muscular Dystrophy Intervention: Drug: Ataluren Sponsor: PTC Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Angioplasty | Coronary Angioplasty | Muscular Dystrophy | Reflex Sympathetic Dystrophy | Research | Study